Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of

Yoshitaka Adachi1, Seitaro Terakura2, Masahide Osaki3

  • 1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. yadachi@umich.edu.

Nature Communications
|December 10, 2024
PubMed

Insights

Genetic ablation of CUL5 enhances chimeric antigen receptor (CAR) T cell therapy. Knocking out CUL5 improves CAR T cell expansion and effector functions, boosting cancer immunotherapy outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Chimeric antigen receptor (CAR) T cell therapy shows promise for cancer treatment.
  • Identifying factors to enhance CAR T cell efficacy is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify genes regulating CAR T cell proliferation and survival using genome-wide CRISPR screening.
  • To investigate the role of CUL5 in CAR T cell function and therapeutic potential.

Main Methods:

  • Genome-wide CRISPR screening was employed to identify genes affecting CAR T cell function.
  • CUL5 was genetically ablated in human CD19 CAR T cells.
  • JAK/STAT pathway activation and protein degradation were analyzed.
  • In vivo studies utilized shRNA-mediated knockdown of CUL5 in tumor-bearing mice.

Main Results:

  • Genetic ablation of CUL5 significantly enhanced human CD19 CAR T cell expansion and effector functions.
  • CUL5 knockout CAR T cells exhibited sustained STAT3 and STAT5 phosphorylation.
  • Delayed phosphorylation and degradation of JAK1 and JAK3 were observed in CUL5-deficient CAR T cells.
  • CUL5 knockdown in vivo improved CD19 CAR T treatment outcomes in mice.

Conclusions:

  • Targeting CUL5 within the ubiquitin system can enhance CAR T cell effector functions.
  • CUL5 modulation represents a potential strategy to improve the efficacy of CAR T cell immunotherapy for cancer treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
658